Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 10x Genomics, Inc.TXG · Entity 2172 | Director | June 04, 2026 | June 08, 2026 |
| Penumbra IncPEN · Entity 3430 | President | April 15, 2020 | April 18, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
10x Genomics, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 65,278 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 8,829 · Balance 65,278 F1: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,000 |
Reported balance
Holding disclosure · report date 2026-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,000 F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.
F2: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee.
Penumbra Inc
Report date April 15, 2020 · Filed April 18, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 155,351 |
Last balance in matching sequence
After 2020-04-15 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
7 source rowsRow 1 · 2020-04-15 · Sale · Disposed 200 · Balance 157,651 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2: This transaction was executed in multiple trades at prices ranging from $164.78 to $165.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. Row 2 · 2020-04-15 · Sale · Disposed 100 · Balance 157,551 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3: Shares are held by the Kosaraju Family Trust. Row 3 · 2020-04-15 · Sale · Disposed 300 · Balance 157,251 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4: This transaction was executed in multiple trades at prices ranging from $167.16 to $167.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. Row 4 · 2020-04-15 · Sale · Disposed 217 · Balance 157,034 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5: This transaction was executed in multiple trades at prices ranging from $168.01 to $168.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. Row 5 · 2020-04-15 · Sale · Disposed 600 · Balance 156,434 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6: This transaction was executed in multiple trades at prices ranging from $169.04 to $169.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. Row 6 · 2020-04-15 · Sale · Disposed 383 · Balance 156,051 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F7: This transaction was executed in multiple trades at prices ranging from $170.05 to $170.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. Row 7 · 2020-04-15 · Sale · Disposed 700 · Balance 155,351 F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F8: This transaction was executed in multiple trades at prices ranging from $171.22 to $171.65. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3: Shares are held by the Kosaraju Family Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $164.78 to $165.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3: Shares are held by the Kosaraju Family Trust.
F4: This transaction was executed in multiple trades at prices ranging from $167.16 to $167.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F5: This transaction was executed in multiple trades at prices ranging from $168.01 to $168.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F6: This transaction was executed in multiple trades at prices ranging from $169.04 to $169.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F7: This transaction was executed in multiple trades at prices ranging from $170.05 to $170.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F8: This transaction was executed in multiple trades at prices ranging from $171.22 to $171.65. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEVRO CORP
Report date April 03, 2025 · Filed April 03, 2025
Section 16 reporting ended · disclosed 2025-04-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-04-03 transaction · row 1
1 source rowRow 1 · 2025-04-03 · Disposition to issuer · Disposed 46,575 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time"). F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. ("Globus") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus ("Merger Sub"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the "Effective Time").
F2: At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the "Merger Consideration"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2021 Filed Jun 25, 2021 20:23 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 200 | $197.26 | $39,452.00 |
DisclosureSEC source: 0001209191-21-043307 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,300 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). F2 · price: This transaction was executed in multiple trades at prices ranging from $197.21 to $197.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: These shares are held by the Kosaraju Family Trust. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantStock Option (right to buy) · Derivative | 1,563 | $0.00 Strike: $193.51 | $0.00 |
DisclosureSEC source: 0001209191-21-040686 · doc4.xml · derivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Underlying: Class A Common Stock · 1,563 shares Expires 2031-06-11 F3 · derivative.exercise_date: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:49 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantClass A Common Stock | 625 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040686 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| May 24, 2021 Filed May 27, 2021 00:28 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 100 | $163.04 | $16,304.00 |
DisclosureSEC source: 0001209191-21-036105 · doc4.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,500 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F3 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| May 24, 2021 Filed May 27, 2021 00:28 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 300 | $162.05 | $48,615.99 |
DisclosureSEC source: 0001209191-21-036105 · doc4.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,600 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F5 · price: This transaction was executed in multiple trades at prices ranging from $161.91 to $162.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| May 24, 2021 Filed May 27, 2021 00:28 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 700 | $161.15 | $112,805.49 |
DisclosureSEC source: 0001209191-21-036105 · doc4.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,900 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F4 · price: This transaction was executed in multiple trades at prices ranging from $160.66 to $161.635. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| May 24, 2021 Filed May 27, 2021 00:28 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 400 | $160.05 | $64,020.52 |
DisclosureSEC source: 0001209191-21-036105 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,600 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F2 · price: This transaction was executed in multiple trades at prices ranging from $159.64 to $160.605. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 100 | $194.74 | $19,474.00 |
DisclosureSEC source: 0001209191-21-028637 · doc4.xml · nonDerivative · entry 5 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 600 | $193.98 | $116,385.60 |
DisclosureSEC source: 0001209191-21-028637 · doc4.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,100 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F5 · price: This transaction was executed in multiple trades at prices ranging from $193.72 to $194.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 400 | $193.11 | $77,245.52 |
DisclosureSEC source: 0001209191-21-028637 · doc4.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F4 · price: This transaction was executed in multiple trades at prices ranging from $192.66 to $193.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 300 | $191.71 | $57,513.00 |
DisclosureSEC source: 0001209191-21-028637 · doc4.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,100 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F3 · price: This transaction was executed in multiple trades at prices ranging from $191.50 to $192.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 21:58 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 100 | $190.05 | $19,005.00 |
DisclosureSEC source: 0001209191-21-028637 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,400 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| March 23, 2021 Filed Mar 26, 2021 00:32 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 200 | $178.07 | $35,613.00 |
DisclosureSEC source: 0001209191-21-023107 · doc4.xml · nonDerivative · entry 5 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,500 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F4 · price: This transaction was executed in multiple trades at prices ranging from $177.76 to $178.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F1 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| March 23, 2021 Filed Mar 26, 2021 00:32 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 100 | $175.71 | $17,571.00 |
DisclosureSEC source: 0001209191-21-023107 · doc4.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,700 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F1 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| March 23, 2021 Filed Mar 26, 2021 00:32 UTC | 10x Genomics, Inc. TXG · Entity 2172 | SaleClass A Common Stock | 1,200 | $173.96 | $208,755.00 |
DisclosureSEC source: 0001209191-21-023107 · doc4.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,800 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust. F3 · price: This transaction was executed in multiple trades at prices ranging from $173.48 to $174.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F1 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| January 25, 2021 Filed Mar 26, 2021 00:32 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GiftClass A Common Stock | 7,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023107 · doc4.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,000 F1 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust"). Read SEC document |
| January 25, 2021 Filed Mar 26, 2021 00:32 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GiftClass A Common Stock | 7,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-023107 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833 Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 20:28 UTC | 10x Genomics, Inc. TXG · Entity 2172 | GrantStock Option (right to buy) · Derivative | 4,432 | $0.00 Strike: $88.42 | $0.00 |
DisclosureSEC source: 0001209191-20-037269 · doc4.xml · derivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,432 Underlying: Class A Common Stock · 4,432 shares Expires 2030-06-15 F1 · derivative.exercise_date: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 23:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001209191-20-033305 · doc4.xml · derivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,167 Underlying: Class A Common Stock · 10,000 shares Expires 2029-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, originally for 130,000 shares, of which 20,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares. Read SEC document |
| May 29, 2020 Filed Jun 1, 2020 23:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | Exercise / conversionClass A Common Stock | 10,000 | $11.48 | $114,800.00 |
DisclosureSEC source: 0001209191-20-033305 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 700 | $171.46 | $120,022.00 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 7 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 155,351 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $171.22 to $171.65. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 383 | $170.30 | $65,224.90 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 6 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 156,051 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $170.05 to $170.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 600 | $169.40 | $101,640.00 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 5 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 156,434 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $169.04 to $169.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 217 | $168.41 | $36,544.97 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 157,034 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $168.01 to $168.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 300 | $167.26 | $50,178.00 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 157,251 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $167.16 to $167.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 100 | $166.16 | $16,616.00 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 157,551 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| April 15, 2020 Filed Apr 18, 2020 01:08 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 200 | $164.89 | $32,978.00 |
DisclosureSEC source: 0001321732-20-000063 · wf-form4_158717208520359.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 157,651 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $164.78 to $165.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:55 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 1,800 | $155.46 | $279,828.00 |
DisclosureSEC source: 0001321732-20-000053 · wf-form4_158457572863618.xml · nonDerivative · entry 5 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 157,851 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $155.04 to $155.68. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:55 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 100 | $153.07 | $15,307.00 |
DisclosureSEC source: 0001321732-20-000053 · wf-form4_158457572863618.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 159,651 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:55 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 200 | $152.47 | $30,494.00 |
DisclosureSEC source: 0001321732-20-000053 · wf-form4_158457572863618.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 159,751 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $152.08 to $152.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:55 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 200 | $151.36 | $30,272.00 |
DisclosureSEC source: 0001321732-20-000053 · wf-form4_158457572863618.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 159,951 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $151.02 to $151.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 23:55 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 200 | $150.00 | $30,000.00 |
DisclosureSEC source: 0001321732-20-000053 · wf-form4_158457572863618.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 160,151 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:03 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 300 | $191.51 | $57,453.00 |
DisclosureSEC source: 0001321732-20-000043 · wf-form4_158224699270096.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 160,351 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $191.48 to $191.52. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:03 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 1,700 | $190.79 | $324,343.00 |
DisclosureSEC source: 0001321732-20-000043 · wf-form4_158224699270096.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 160,651 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $190.41 to $191.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:03 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 500 | $189.93 | $94,965.00 |
DisclosureSEC source: 0001321732-20-000043 · wf-form4_158224699270096.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 162,351 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $189.35 to $190.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:18 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 500 | $178.08 | $89,040.00 |
DisclosureSEC source: 0001321732-20-000013 · wf-form4_158077908220860.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 163,851 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $177.79 to $178.38. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:18 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 300 | $177.40 | $53,220.00 |
DisclosureSEC source: 0001321732-20-000013 · wf-form4_158077908220860.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 164,351 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $176.96 to $177.64. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:18 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 500 | $176.01 | $88,005.00 |
DisclosureSEC source: 0001321732-20-000013 · wf-form4_158077908220860.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 164,651 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $175.71 to $176.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:18 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 1,200 | $175.09 | $210,108.00 |
DisclosureSEC source: 0001321732-20-000013 · wf-form4_158077908220860.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 165,151 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $174.71 to $175.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| September 16, 2019 Filed Sep 16, 2019 20:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | OtherStock Option (right to buy) · Derivative | 119,167 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0000899243-19-023634 · doc4.xml · derivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,167 Underlying: Class A Common Stock · 119,167 shares Expires 2029-05-10 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F3 · derivative.exercise_date: This option, originally for 130,000 shares, of which 10,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares. F1 · derivative.underlying: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. Read SEC document |
| September 16, 2019 Filed Sep 16, 2019 20:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | OtherStock Option (right to buy) · Derivative | 119,167 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0000899243-19-023634 · doc4.xml · derivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 119,167 shares Expires 2029-05-10 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F3 · derivative.exercise_date: This option, originally for 130,000 shares, of which 10,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares. F1 · derivative.underlying: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. Read SEC document |
| September 16, 2019 Filed Sep 16, 2019 20:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | OtherClass A Common Stock | 10,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-023634 · doc4.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,833 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee. Read SEC document |
| September 16, 2019 Filed Sep 16, 2019 20:16 UTC | 10x Genomics, Inc. TXG · Entity 2172 | OtherClass B Common Stock | 10,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-023634 · doc4.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Class B Common Stock was reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering. F2 · ownership.nature: These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee. Read SEC document |
| August 26, 2019 Filed Feb 15, 2020 01:04 UTC | Penumbra Inc PEN · Entity 3430 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-20-000039 · wf-form5_158172864014765.xml · nonDerivative · entry 1 Kosaraju Sridhar · CIK 0001651325 · President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 165,351 F1 · kind: This was a bona fide gift with no payment in consideration. F2 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 100 | $172.31 | $17,231.00 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 7 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 166,351 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 600 | $171.65 | $102,990.00 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 6 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 166,451 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $171.28 to $172.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 1,505 | $170.66 | $256,843.30 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 5 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 167,051 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $170.26 to $171.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 400 | $169.60 | $67,840.00 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 4 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 168,556 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $169.28 to $169.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 740 | $168.56 | $124,734.40 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 3 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 168,956 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $168.36 to $168.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
| August 01, 2019 Filed Aug 3, 2019 00:09 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 1,049 | $167.89 | $176,116.61 |
DisclosureSEC source: 0001321732-19-000086 · wf-form4_156479094219005.xml · nonDerivative · entry 2 Kosaraju Sridhar · CIK 0001651325 · CFO and Head of Strategy 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 169,696 F1 · kind: The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $167.46 to $168.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Shares are held by the Kosaraju Family Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.